This suggests that CORT treatment induces muscle GR–independent systemic insulin resistance initially but induces muscle GR–dependent insulin resistance via the induction of hyperinsulinemia during long-term CORT treatment. This evidence concerns the gene NR3C1 and hyperinsulinism.